Back to search

Article

Homology mediated end joining enables efficient non-viral targeted integration of large DNA templates in primary human T cells

2021-11-13

Abstract excerpt

Adoptive cellular therapy using genetically engineered immune cells holds tremendous promise for the treatment of advanced cancers. While the number of available receptors targeting tumor specific antigens continues to grow, the current reliance on viral vectors for clinical production of engineered immune cells remains a significant bottleneck limiting translation of promising new therapies. Here, we describe an...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
749990c7-0d29-534b-aa01-8d6686dccefe
DOI
10.1101/2021.11.12.468427
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Homology mediated end joining enables efficient non-viral targeted integration of large DNA templates in primary human T cellsDOI 10.1101/2021.11.12.468427
Select a neighboring publication to make it the new centre.